"Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and ranks 55th on the Fortune 500 list of the largest U.S. corporations by total revenue. The Wall Street white-glove giant offers financing, advisory services, risk distribution, and hedging for the firm's institutional and corporate clients. We review the firm's Conviction List of top stock ideas monthly, seeking companies with the highest dividends, safe profiles, and the greatest upside relative to the firm's target price objectives."
"The Goldman Sachs Conviction List is a curated list of stocks that the firm's research team believes are highly likely to outperform the market. It is a tool for investors to identify stocks with strong growth potential, frequently updated to reflect changes in market conditions and company performance. The list aims to identify stocks where Goldman Sachs analysts have the "highest level of conviction" in their outperformance."
Goldman Sachs was founded in 1869 and is the world's second-largest investment bank by revenue, ranking 55th on the Fortune 500 by total revenue. The firm provides financing, advisory services, risk distribution, and hedging for institutional and corporate clients. The Conviction List identifies stocks in which the research team has the highest level of conviction in future outperformance and is updated frequently to reflect market and company changes. The list emphasizes stocks with high dividends, safe profiles, and upside relative to target prices. Five listed stocks show significant upside and reliable dividends. Abbott Laboratories offers a 2.20% dividend and operates four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]